Organization

Claude Huriez Hospitals, Lille University Hospital, Lille, France

3 abstracts

Abstract
Pembrolizumab (pembro) in patients (pts) with sorafenib-treated (cohort 1) and treatment (tx)-naive (cohort 2) advanced hepatocellular carcinoma (aHCC) after additional follow-up in the phase 2 KEYNOTE-224 study.
Org: Saint-Luc University Clinics, Brussels, Belgium, Eugène Marquis Center, Rennes, France, Claude Huriez Hospitals, Lille University Hospital, Lille, France, Ghent University Hospital, Ghent, Belgium, CR UK Liverpool Experimental Cancer Medicine Centre and Clatterbridge Cancer Centre, Liverpool, United Kingdom,
Abstract
ADHERENCE TO HYDROXYCHLOROQUINE AS ASSESSED BY MEASUREMENTS OF DRUG AND METABOLITE BLOOD LEVELS IN AN INTERNATIONAL PROSPECTIVE STUDY OF SLE PATIENTS IN FLARE
Org: Cochin Hospital, Cliniques Universitaires Saint-Luc, NYU Langone Medical Center, University of Santo Tomas Hospital - Benavides Cancer Institute, Rush University Medical Center,
Abstract
ARTICULAR MANIFESTATIONS OF POLYMYOSITIS WITH ANTI-SYNTHETASE SYNDROME
Org: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Bichat Hospital, Medecine interne, Claude Huriez Hospitals, Lille University Hospital, Lille, France, Pitié Salpétrière,